India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
I T C Lt 285.10 1.91
Axis Ban 505.95 2.19
State Ba 281.95 1.55
Tata Stl 445.75 1.87
Tata Mot 455.95 1.14
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Glenmark Pharmaceutical Limited
Glenmark Pharmaceutical Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:532296NSE:GLENMARKBloomberg:GNP@INReuters:GLEN.BO
Market Lot: 1Face Value: 1ISIN Demat: INE935A01035
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
25-Apr-2017       Glenmark Pharma initiates clinical investigation for GBR 310 IRIS
19-Apr-2017       Glenmark Pharma receives tentative approval for generic Pradaxa capsules IRIS
10-Apr-2017       Glenmark Pharma gets nod for generic Tricor Micronized capsules IRIS
31-Mar-2017       Glenmark Pharma receives tentative nod for Milnacipran HCl tablets IRIS
30-Mar-2017       Glenmark Pharmaceuticals reports positive results from phase 3 trial of GSP 301 IRIS
21-Mar-2017       Glenmark Pharma secures USFDA nod for Clobetasol Propionate ointment IRIS
20-Mar-2017       Glenmark Pharma gets USFDA nod for Fingolimod capsules IRIS
15-Mar-2017       Glenmark Pharma receives EIR from USFDA for Ankleshwar plant IRIS
08-Mar-2017       Glenmark Pharma receives USFDA nod for IND GSP 304 IRIS
02-Mar-2017       Glenmark Pharma, Evestra ink pact for generic NuvaRing IRIS
03-Feb-2017       Glenmark Pharma quarterly earnings zoom 2.43 times  IRIS
27-Dec-2016       Glenmark Pharma receives USFDA approval for Tretinoin capsules IRIS
19-Dec-2016       Glenmark Pharma unveils strategic blueprint on innovative NME IRIS
13-Dec-2016       Glenmark Pharma launches generic version of Zetia in US IRIS
28-Oct-2016       Glenmark pharma rises after good Q2 results IRIS
27-Oct-2016       Glenmark Pharmaceutical quarterly profit climbs 3.5%  IRIS
25-Oct-2016       Glenmark gets USFDA approval for generic Mycolog-II IRIS
19-Sep-2016       Glenmark Pharma gets global exclusive marketing & distribution rights for Abraxane IRIS
14-Sep-2016       Glenmark Pharma receives USFDA nod for Diclofenac Sodium gel IRIS
12-Sep-2016       Glenmark Pharma receives USFDA nod for Lidocaine ointment IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer